
Conference Coverage
Latest Content

MS Not Linked to Higher Mortality in Cardiovascular Surgery

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

3+1 Lymph Node Sampling Not Associated With Increased Postoperative Complications in NSCLC

GLP-1 Therapies in 2026: Beyond Blood Sugar and the Scale

ACA Enrollment Erosion Deepens After Open Enrollment Ends

Shorts










Podcasts
Center on Health Equity & Access
All News

The treatment worked in patients with generalized myasthenia gravis (gMG) regardless of previous immunosuppressive treatment or concomitant use of other gMG treatments.

Alopecia areata shapes how people work, learn, and see themselves, a new occupational review finds, with barriers reaching far beyond hair loss.

Rural America has 44% fewer health care workers per capita than urban areas, with psychologists and physicians hit hardest.

New ADA 2026 data show diabetic ketoacidosis hospitalizations rising 24%, driven by poor ketone monitoring and symptom recognition gaps across all ages.

Orforglipron added to titrated insulin glargine reduced HbA1c at 40 weeks while producing clinically meaningful weight reductions.

Despite increases in influenza vaccine rates before the pandemic in the Bronx, rates have decreased between 2020 and 2023.

GLP-1 medications in psoriasis show skin and inflammation gains beyond weight loss; early data in psoriatic arthritis lag as trials ramp up.

The dual glucagon/GLP-1 receptor agonist is also being studied in the SYNCHRONIZE-2, SYNCHRONIZE-CVOT, LIVERAGE, and LIVERAGE-Cirrhosis trials.

Real-world diabetic macular edema care lags trials as fewer VEGF injections and step therapy limit outcomes.

A total of 2288 cases of measles were confirmed in the US for the full year of 2025, suggesting that the cases are set to double in 2026.

















